Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment

INTRODUCTION: Plasma glial fibrillary acidic protein (GFAP) is a marker of astroglial activation and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer’s disease (AD) pathology in the form of AD-related amyloid-β (Aβ) pathology and conversion to AD dementia in a mild cognitive...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Res Ther
Main Authors: Cicognola, Claudia, Janelidze, Shorena, Hertze, Joakim, Zetterberg, Henrik, Blennow, Kaj, Mattsson-Carlgren, Niklas, Hansson, Oskar
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2021
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8005231/
https://ncbi.nlm.nih.gov/pubmed/33773595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-021-00804-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares